LIQUID BIOPSY MARKETS by Cancer Type by Diagnosis, Monitoring & Recurrance Testing. 2019-2023 w. Historical Including Screening Market Potential Size with Executive and Consultant Guides


Publication Date: Feb.1, 2018   251 Pages.  Our facts.  Your success.

With our complimentary research project service, it is like your report is FREE!  Our reports include, without charge, a research project under your direction. Take advantage of this to get specific information that is not in the report already. Ask us about what info you need .

Blood Tests replace Surgical Biopsies. Single screening test for all cancers announced .....”

 The Diagnostic, Monitoring and Screening opportunities are explored.

A revolution in cancer diagnostics is occurring using in vitro blood testing to identify cancer DNA.  The technology creates new markets for cancer screening tests.

GRAIL, a new company with impressive backing, has announced a single blood test to detect all cancers.  The technology is moving faster than the market.  New technology that definitively identifies disease conditions from blood samples is poised to replace expensive invasive surgical biopsy procedures.  The market is still in its infancy but has outstanding growth potential.  The impact on the health care industry is enormous.  The report forecasts the market size out to 2020.  In addition, the report looks at potential market sizes by country, by cancer and by the three different opportunities: detection, management and screening.

Use independent research that makes you the expert. Get our research team working for you by ordering this comprehensive report.  Your credit card order sends the report to your inbox instantly.  Check all your licensing options but don't worry, your order is available as a credit if you wish to upgrade to more information. Get an extra player on your team as unlimited assistance and breakout data is included with your purchase.

 Circulating Tumor Cells?  Cell Free DNA?  Exosomes?  Find out about the technology in readily understood terms that explain the jargon.  Find the opportunities and the pitfalls.  Understand growth expectations and the ultimate potential market size.

The report includes detailed breakouts for 15 Countries and 4 Regions along with breakouts for Lung, Breast, Colorectal, Prostate and Other Cancers as well as breakouts by Diagnostic, Therapy Monitoring and Recurrence Monitoring. 


What is the size of the huge screening opportunity?  They are all listed in Chapter 10.


See the Table of Contents.

See the Sample Data Pages

All report data is available in Excel format on request.

Make investment decisions and valuations with confidence using the latest data.  



Mr. Greg Powell, B.SC., M.B.A is the President of Howe Sound Research. 


He is an experienced business and clinical professional.  He is co-author of the paper "The Radioimmunoassay of Angiotensinogen by Antibody Trapping."  He has worked in laboratory testing and management for over 20 years.  Mr. Powell’s education includes:

B.Sc. (Chemistry) University of BC

M.B.A. (Finance and Policy) University of BC

Market Research  - Burke Institute

Finance for Senior Executives - Harvard Business School

Related products